TSX:APTX
Apotex Health Corp. · TSX · Healthcare · CAD · FY for 2026
Figures on this page computed 2026-11-08 00:01 UTC
Last close
n/aCAD
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
21.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
- Computed from the filing for 2026
19.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
10.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
13.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
What it pays out is the furthest below its sector's middle: 0.10 against 0.54 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2026
- Sales1.07x
Its own average over 3 years, 3.26B.
- Profit2.96x
Its own average over 3 years, 126.2M.
- Free cash flow1.12x
Its own average over 3 years, 409.6M.
- Debt1.31x
Its own average over 3 years, 2.68B.
- Pricen/a
Its own average over 0 years. Market data
Profit is furthest from its own average, at 2.96 times.
The filed years, as a table
3Each line is 100 at 2024-03-31, the first year we hold.
| Filed year | Sales | Shares in issue |
|---|---|---|
| 2024-03-31 | 100.0 | 100.0 |
| 2025-03-31 | 113.9 | 100.0 |
| 2026-03-31 | 118.7 | 101.4 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- CAD
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- CAD
Figures behind the shape
Growth
146.4%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
One-year change in net income146.4%
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
Returns on capital
19.4%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capital19.4%
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on equityn/mnegative equity
Negative equity.
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Return on assets8.2%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Margins
55.6%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin55.6%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Operating margin22.5%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Net margin10.7%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Free cash flow margin13.2%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Price
21.4xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings21.4x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
- Computed from the filing for 2026
Price to bookn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
- Computed from the filing for 2026
- computed
- Computed from the filing for 2026
EV to EBITDA12.6x
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Price to sales ratio2.3x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
- Computed from the filing for 2026
- Computed from the filing for 2026
Safety
1.50safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Current ratio1.50
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Interest coverage3.2x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
Altman Z-Score2.17
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
What it pays out
296.9%more, and better covered, is higher, placed against 1,091 companies as of 2026-11-07
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
Payout ratio296.9%
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
Dividend cover ratio0.4x
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- CAD
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.